BamSEC and AlphaSense Join Forces
Learn More

Akesis Pharmaceuticals, Inc.

Material Contracts Filter

EX-10.1
from 8-K 10 pages Akesis Pharmaceuticals, Inc. Stand-Alone Stock Option Agreement
12/34/56
EX-10.1
from 8-K 15 pages Akesis Pharmaceuticals, Inc. Note and Warrant Purchase Agreement
12/34/56
EX-10.1
from 8-K 10 pages Akesis Pharmaceuticals, Inc. Stand-Alone Stock Option Agreement
12/34/56
EX-10.1
from 8-K 11 pages Revised Letter of Payment Authorization
12/34/56
EX-10.1
from 8-K 10 pages Akesis Pharmaceuticals, Inc. Stand-Alone Stock Option Agreement
12/34/56
EX-10.1
from 8-K 5 pages Consulting Services Agreement
12/34/56
EX-10.15
from 10KSB 12 pages Akesis Pharmaceuticals, Inc. Securities Purchase Agreement
12/34/56
EX-10.1
from 8-K 9 pages Akesis Pharmaceuticals, Inc. Stand-Alone Stock Option Agreement
12/34/56
EX-10.2
from 8-K 5 pages Letter of Payment Authorization
12/34/56
EX-10.1
from 8-K 5 pages Letter of Payment Authorization
12/34/56
EX-10.2
from 8-K 4 pages March 14, 2007 Qlt Inc. 887 Great Northern Way, Vancouver, British Columbia, V5t 4t5 Attention: Robert Butchofsky, President and Chief Executive Officer, Re: Documentation Regarding Investigational New Drug Application, Filed by Kinetek Pharmaceuticals Inc. Dated November 5, 1998 (Ind Serial No. 57,249) (The “Kinetek Ind”) and Canadian and International Equivalents
12/34/56
EX-10.1
from 8-K 28 pages License Agreement
12/34/56
EX-10.1
from 8-K 15 pages Akesis Pharmaceuticals, Inc. Securities Purchase Agreement
12/34/56
EX-10.2
from 8-K 5 pages Akesis Pharmaceuticals, Inc. 888 Prospect Street Suite 320 La Jolla, Ca 92037 Gentlemen: 1. Engagement. This Letter Will Confirm the Agreement Between Akesis Pharmaceuticals., Inc. (The “Company”) and Globalvest Partners, LLC (The “Finder” or “Globalvest”) in Connection With a Possible Equity Investment in the Company (Collectively, the “Transaction”)
12/34/56
EX-10.1
from 8-K 22 pages Akesis Pharmaceuticals, Inc. Securities Purchase Agreement November 21, 2006
12/34/56
EX-10.4
from 8-K/A 3 pages Akesis Pharmaceuticals, Inc. October 2, 2006
12/34/56
EX-10.3
from 8-K/A 9 pages Akesis Pharmaceuticals, Inc. Form of Stand-Alone Stock Option Agreement
12/34/56
EX-10.2
from 8-K/A 8 pages Akesis Pharmaceuticals, Inc. Warrant to Purchase Common Stock
12/34/56
EX-10.1
from 8-K/A 8 pages Separation Agreement and Release
12/34/56
EX-10.4
from 8-K 3 pages Akesis Pharmaceuticals, Inc. October 2, 2006
12/34/56